O,O-diisopropyl-S-benzylthiophosphate (IBP)

06/01/2020 - "Several case reports and observational studies have reported serious musculoskeletal side effects; however, the incidence, imaging findings, and longitudinal follow-up data are limited for patients who develop inflammatory back pain (IBP). "
01/01/2017 - "In the present study, we conducted a telephone survey for screening inflammatory back pain (IBP) in the community. "
07/01/2016 - "In this study population, IBP characteristics were in general common and the discriminative value was low, as IBP could not differentiate patients with SpA according to ASAS criteria from patients with other causes of back pain."
03/09/2012 - "The studies required a group with either SpA or inflammatory back pain (IBP) and a non-case group without SpA or IBP. "
11/02/2023 - "For the clinical definitions of axial involvement 'global assessment', 'detailed assessment', 'back pain (BP)' and 'inflammatory BP (IBP)' the probabilities of developing syndesmophytes ranged between 0.06 and 0.08 and were similar for the presence or absence of the definition. "

11/01/2020 - "Features of IBP include insidious onset before age 45 years, association with morning stiffness, improvement with exercise but not rest, alternating buttock pain, and good response to treatment with nonsteroidal anti-inflammatory drugs. "
12/01/2021 - "IBP, buttock pain, enthesitis, elevated baseline CRP levels and SIJ-MRI positivity in patients with the disease are associated with higher risk of progression to JoAS."
03/13/2021 - "We suggest that the occurrence of retroauricular pain before the onset of facial weakness is associated with higher severity of IBP while the occurrence after the onset is associated with lower severity of IBP."
01/01/2019 - "Scores of pain intensity and pain interference, disease activity, and functional limitation were significantly higher in patients with IBP or NP than those without either (P < 0.05). "
01/01/2019 - "The presence of IBP or NP, pain intensity and quality, pain interference, disease activity, and functional status were assessed. "

04/01/2017 - "Implementing a referral strategy that identifies patients with IBP for additional testing and assessment may lead to better recognition of early signs and symptoms of AxSpA, thereby offering the potential for improved patient outcomes. "
09/01/2015 - "The prevalence estimates of IBP and axSpA reported here are within the upper range of other studies in European countries and the United States."
10/01/2023 - "Not requiring IBP as mandatory for diagnosis of axSpA (algorithm M2) provides more value and would be preferable. "
01/01/2022 - "Recognition of IBP is important for timely referral of patients with suspected axSpA to a rheumatologist. "
01/01/2022 - "Prevalence of MRI-defined axSpA was low and showed poor agreement with IBP and axSpA criteria."

01/01/2019 - "In this review, we summarize and compare the present knowledge on this important, yet still poorly understood aspect of pathogenesis of human viral and especially IBP infections."
01/01/2019 - "However, the still scant data suggest that similar mechanisms may also determine the reprogramming of the host cell metabolism in IBP infections. "
01/01/1977 - "On farms with a record of active IBP--IPV infection it is suggested to treat both the diseased and apparently (clinically) normal calves, either therapeutically or prophylactically, with a hyperimmune serum, and after the disease has receded--to resort to vaccination. "
01/01/2023 - "Nevertheless, dramatic differences between IBP and viral infections were also observed, and clearly distinguished the two types of intracellular infections. "
07/01/2012 - "In recent IBP suggestive of SpA, uveitis is associated with IBD and infection. "

11/01/2012 - "The data show that the Ibp produced an important reduction in glioma tumour cell proliferation in the rat model."
11/01/2012 - "After stereotactic injection of C6/LacZ rat glioma cells into the Wistar rats brain, the rats were randomly assigned to two treatment groups (group 1, control; group 2, Ibp treatment). "
09/01/2010 - "The ruthenium compound [Ru(2)Cl(Ibp)(4)] (or RuIbp) has been reported to cause significantly greater inhibition of C6 glioma cell proliferation than the parent HIbp. "
12/11/2012 - "T98G human glioma cells were treated with IBP, PGE(1) or PGE(2) at varying concentrations for 24-72 hours. "
11/01/2012 - "To determine the effects of ibuprofen (Ibp) on the vessel proliferation and necrosis in a rat glioma model. "